Ob-Gyn Coding Alert

Reader Questions:

You May Report 82270 for Non-Medicare Patients

Question: How should I report the obtaining of a stool smear at the time of a rectal exam if my ob-gyn uses a liquid developer (Seracult) to determine if blood exists in the stool? What about for the diagnosis?

Kansas subscriber Answer: For a Medicare patient, you should report nothing, because the patient is required to collect the sample. However, if your ob-gyn treats a non-Medicare patient and the carrier does not follow Medicare rules, you can report 82270 (Blood, occult, by peroxidase activity [e.g., guaiac], qualitative; feces, 1-3 simultaneous determinations). You should choose this code because the Seracult test is a simplified, standardized variation of the guaiac test.
 
As for the diagnosis, you can generally use either V76.51 (Special screening for malignant neoplasms, colon) or V76.41 (Special screening for malignant neoplasms, rectum).
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Ob-Gyn Coding Alert

View All